title: [Severe diffuse facial cellulitis].
abstract: Twenty cases of severe cervicofacial infections among 184 cases of cellulites treated in 1991 and 1992 at the Lille University Hospital were investigated. Outcome was compared with results reported in the literature. Outcomes were similar and emphasized the critical nature of this type of infection which caused 7 deaths in our series and severe anatomic and functional sequelae. All patients (n = 20) were given anti-inflammatory drugs prior to surgery. The correlation between disease severity and use of anti-inflammatory drugs would appear to be an established fact. Criteria predicting severity were identified in order to obtain a score for high or low risk and to better adapt the medical and surgical management strategy.
authors.affiliation: Service de stomatologie et chirurgie maxillo-faciale du Pr. M. Donazzan Höpital B CHRU de Lille.
authors.forename: C
authors.initials: C
authors.lastname: Rose
authors.forename: C
authors.initials: C
authors.lastname: Tellion
authors.forename: F
authors.initials: F
authors.lastname: Ferri
authors.forename: M
authors.initials: M
authors.lastname: Donazzan
mesh_terms: D000293:Adolescent; D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D001424:Bacterial Infections / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology / Q000601:surgery; D002423:Cause of Death; D002481:Cellulitis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology / Q000503:physiopathology / Q000601:surgery; D002648:Child; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005145:Face; D005260:Female; D005544:Forecasting; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D009333:Neck; D010406:Penicillins / Q000627:therapeutic use; D010878:Piperacillin / Q000627:therapeutic use; D011292:Premedication; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D010406:Penicillins; D008795:Metronidazole; D000583:Amikacin; D010878:Piperacillin